TrianglePUBLICATIONS · 33439693
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2021 Feb 20
- First author
- Liu SV
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Liu SV
- type
- Author
- name
- Reck M
- type
- Author
- name
- Mansfield AS
- type
- Author
- name
- Mok T
- type
- Author
- name
- Scherpereel A
- type
- Author
- name
- Reinmuth N
- type
- Author
- name
- Garassino MC
- type
- Author
- name
- De Castro Carpeno J
- type
- Author
- name
- Califano R
- type
- Author
- name
- Nishio M
- type
- Author
- name
- Orlandi F
- type
- Author
- name
- Alatorre-Alexander J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Liu SV
- type
- Author
- name
- Reck M
- type
- Author
- name
- Mansfield AS
- type
- Author
- name
- Mok T
- type
- Author
- name
- Scherpereel A
- type
- Author
- name
- Reinmuth N
- type
- Author
- name
- Garassino MC
- type
- Author
- name
- De Castro Carpeno J
- type
- Author
- name
- Califano R
- type
- Author
- name
- Nishio M
- type
- Author
- name
- Orlandi F
- type
- Author
- name
- Alatorre-Alexander J
- type
- Author
- bibliography ids
- nci-bib-f3c297e426a4c71b58b35ef2
- book metadata
- content sha256
- db15e21d34c53f7ca39eae1f84c14ac835493043c9db131920534e9004c16783
- document type
- citation
- dois
- 10.1200/JCO.20.01055
- electronic publication date
- display
- 2021 Jan 13
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33439693
- immutable id
- pubmed:33439693@db15e21d34c53f7ca39eae1f84c14ac835493043c9db131920534e9004c16783
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 6
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 619-630
- volume
- 39
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 33439693
- provenance
- batch id
- 9bca82d1bba2b27adc79
- provider
- NCBI PubMed ESummary
- record sha256
- defc9ff8872649eac3dbbb7ccd4f79469195f9d16c92e2b7aa6d786e0485c65f
- response sha256
- c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
- retrieved at
- 2026-09-09T23:47:56.131551+00:00
- publication date
- display
- 2021 Feb 20
- precision
- day
- year
- 2021
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133).
Preserved source evidence · Not medical advice